Latest Asx News

Lion Rock Minerals has confirmed a major expansion of its mineralised footprint at the Minta Rutile and Monazite Projects in Cameroon, backed by significant funding rounds including a strategic partnership with Tronox Holdings. The company is well-positioned to accelerate exploration and resource definition into 2026.

Great Northern Minerals Limited has issued a prospectus for an underwritten offer of up to 10,000 listed options at an exercise price of $0.02 each, aiming to facilitate their quotation and trading on the ASX.

Clarity Pharmaceuticals has responded to ASX queries clarifying the timing and materiality of its SAR-bisFAP data presentation, denying the information was price sensitive despite a notable share price rise.

Riedel Resources has finalized drilling plans for its high-grade Kingman Gold Project in Arizona and secured $1.4 million through equity raises to fund upcoming exploration and development activities.

Golden Dragon Mining Ltd is set to raise $5 million through an IPO, aiming for ASX listing with a portfolio of promising gold and nickel exploration projects in Western Australia.

Brazilian Critical Minerals has reported exceptional results from its in-situ recovery trials at the Ema rare earth project, achieving rare earth concentrations far exceeding in-situ grades and securing strong local government backing.

Pearl Gull Iron Limited has entered a binding agreement to sell its Cockatoo Island Project for A$4.5 million in cash, a 4% equity interest in Crestlink Pty Ltd, and royalties on extracted materials, with completion expected in Q4 2025.

Aldoro Resources has confirmed a substantial inferred mineral resource at its Kameelburg Rare Earth Element and Niobium project in Namibia, with Phase II drilling underway targeting high-grade zones. The company also moves to streamline its portfolio by divesting non-core assets.

Richmond Vanadium Technology reports solid progress in its Queensland vanadium project, advancing environmental approvals and feasibility studies while strengthening key industry collaborations.

Cambium Bio has locked in a significant R&D tax rebate and forged three strategic partnerships, underpinning its Phase 3 clinical trials for its lead ophthalmology biologic. The company’s recent capital raise further strengthens its runway as it prepares for pivotal trial milestones.

Corella Resources reports a cautious quarter with a $424,000 cash balance as it reassesses exploration plans at its Tampu Project and considers new ventures to boost shareholder value.

MCS Services Limited reported a $644k cash outflow from operations in Q1 2025 while lodging multiple traffic management tenders and exploring growth strategies. The company continues to consider selling its Traffic Business subsidiary, Highways Traffic Pty Ltd.